echoloc

Pulsetto Tech Stack

Wearable vagus nerve stimulation device with FDA/CE regulatory pathway

Health and Human Services Vilnius 11–50 employees Founded 2021 Public Company

Pulsetto makes a wearable neuromodulation device paired with a mobile app targeting stress, anxiety, and sleep disorders. The company is mid-regulatory approval (FDA 510(k) and EU MDR certification in progress) while scaling customer acquisition through paid media—a capital-intensive phase reflected in their hiring focus: 5 of 9 open roles are marketing-focused, concentrated at senior and lead levels. Tech stack is lean (ARM Cortex-M firmware, Bluetooth, AWS backend, Shopify for commerce) with NetSuite adoption signaling shift toward enterprise financial systems as they prepare for volume.

Tech Stack 13 technologies

Core StackGoogle Ads Meta Ads Shopify AWS Dynamics 365 Bing Ads AppLovin LiveIntent C/C++ ARM Cortex-M Bluetooth Low Energy Excel
AdoptingNetSuite

What Pulsetto Is Building

Challenges

  • Scaling paid media
  • Reducing cac
  • Managing large budgets
  • Driving down cac
  • Boosting roas
  • Unlocking new revenue streams
  • Removing internal documentation bottlenecks
  • Improving regulatory readiness
  • Avoiding delays from missing info
  • Supporting version 3 product launch

Active Projects

  • Structured testing roadmaps
  • New growth channels
  • Monetization models
  • New product launches
  • Fda 510(k) and eu mdr certification processes
  • Regulatory updates implementation
  • Version 3 product launch
  • Device programming
  • High-volume influencer gifting campaigns
  • Sops for gifting and influencer workflows

Hiring Activity

Steady9 roles · 3 in 30d

Department

Marketing
5
Engineering
1
Finance
1
Legal
1
Sales
1

Seniority

Senior
4
Lead
2
Director
1
Manager
1
Mid
1
Company intelligence

Find more companies like Pulsetto by tech stack, pain points and active projects

Get started free

About Pulsetto

Pulsetto is a medtech and wearables company founded in 2021, headquartered in Vilnius, Lithuania, with 11–50 employees. The product is a non-invasive vagus nerve stimulation (VNS) device designed to reduce stress and improve sleep through neuromodulation. The company operates a direct-to-consumer model (Shopify-based) while pursuing regulatory approval pathways in the US (FDA 510(k)) and Europe (MDR). Current execution focuses on version 3 product launch, paid-media customer acquisition (Google, Meta, Bing, affiliate networks), and regulatory compliance—with active hiring in Lithuania and the United States concentrated in marketing leadership and senior roles.

HeadquartersVilnius
Company Size11–50 employees
Founded2021
Hiring MarketsLithuania, United States

Frequently Asked Questions

What is Pulsetto's product and how does it work?

Pulsetto makes a wearable vagus nerve stimulation (VNS) device paired with a mobile app. It's a non-invasive neuromodulation tool designed to reduce stress and anxiety, improve sleep, and enhance heart rate variability through targeted nerve stimulation.

Is Pulsetto FDA approved?

Pulsetto is actively pursuing FDA 510(k) and EU MDR certification as of the data snapshot. Regulatory approval processes are documented as an active project; certification status should be verified directly with the company.

What tech stack does Pulsetto use?

Pulsetto uses ARM Cortex-M microcontrollers, Bluetooth Low Energy for device connectivity, AWS for backend infrastructure, Shopify for e-commerce, and Microsoft Dynamics 365 for CRM. The company is adopting NetSuite for financial management.